Catabasis Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
30,474.00
14,668.00
62,780.00
38,527.00
16,369.00
37,570
Other Current Assets
107.00
354.00
772.00
1,001.00
1,094.00
1,345
Total Current Assets
30,581.00
15,022.00
63,552.00
39,528.00
17,463.00
38,915
Net Property, Plant & Equipment
308.00
288.00
504.00
568.00
321.00
56
Total Investments and Advances
113.00
113.00
113.00
113.00
113.00
113
Other Assets
-
541.00
-
-
-
85
Total Assets
31,002.00
15,964.00
64,169.00
40,209.00
17,897.00
39,169
ST Debt & Current Portion LT Debt
-
309.00
3,173.00
3,243.00
2,479.00
Accounts Payable
-
-
-
-
773.00
Other Current Liabilities
2,930.00
3,925.00
4,606.00
5,082.00
2,764.00
Total Current Liabilities
2,930.00
4,234.00
7,779.00
8,325.00
6,016.00
Long-Term Debt
-
4,439.00
5,720.00
2,479.00
-
Other Liabilities
110.00
198.00
177.00
319.00
89.00
Total Liabilities
3,040.00
8,871.00
13,676.00
11,123.00
6,105.00
Common Equity (Total)
52,184.00
73,053.00
50,493.00
29,086.00
11,792.00
Total Shareholders' Equity
27,962.00
7,093.00
50,493.00
29,086.00
11,792.00
Total Equity
27,962.00
7,093.00
50,493.00
29,086.00
11,792.00
Liabilities & Shareholders' Equity
31,002.00
15,964.00
64,169.00
40,209.00
17,897.00
Preferred Stock (Carrying Value)
80,146.00
80,146.00
-
-
-
About Catabasis Pharmaceuticals
View Profile
